Biosimulation Market is Expected to Witness a CAGR of 15.4% By 2026

Biosimulation Market Size, Share, Trend,
Outlook, Future Analysis And Synthesis By
Biosimulation plays important role in research and development process. Biosimulation is widely used in
consumer personalized medicine, owing to increasing demand for personalized medicine in offering
tailored solutions for various treatment areas such as drug discovery, oncology, cardiology, infectious
disease, and psychiatry. Predictive biosimulation offers effective platform to use biological data and
mathematical modeling to create a virtual version of patient to test simulated treatments.
Moreover, continuous research is being conducted to create a low-priced or open source version of
predictive biosimulation platforms for self-tracking and modeling using patient’s data and to speed up
the adoption by software development communities to generate future health scenarios using patient’s
medication data.
Get In-Depth Sample Copy of This Research @
Market Dynamics
Market players are engaged in developing novel biosimulation platform, in order to offer tailored
solution in each therapeutic area. This is expected to aid in growth of the market. For instance, in
October 2013, Rhenovia Pharma: a biotechnology firm specialized in biosimulation has developed the
first simulator for biological mechanism of epilepsy. Moreover, development of new simulator opens new
possibilities for research in epilepsy treatment. Rhenovia’ new simulator replicates the basic biological
mechanisms of signal transmission between brain cells and simulates its defects leading to epileptic
patterns, thereby leading to prevent epileptic seizures.
Growing support from heathcare regulatory organizations in the adoption of biosimulation based
software and services will, augment future growth of biosimulation market. Current FDA and
EMA guidelines recommends the use of biosimulation in pediatric drug development studies,
thereby minimizing the impact on children that must enroll in clinical trials. For instance, in
Novembr 2017, Certara stated that U.S. Food and Drug Administration (FDA), expanded its use
of Certara’s PBPK Simcyp Population-based Simulator and its Pediatric and Cardiac Safety
Simulators. In addition, under the new agreement, FDA has tripled its number of licenses,
equipping its Modeling and Simulation (M&S) review team with almost 60 PBPK licenses.
Report includes chapters which deeply display the following deliverable about industry :
• Biosimulation Market Research Objective and Assumption
• Biosimulation Market Purview - Report Description, Executive Summary, and Coherent
Opportunity Map (COM)
• Biosimulation Market Dynamics, Regulations, and Trends Analysis - Market Dynamics,
Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals,
Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Biosimulation Market, By Regions
• Biosimulation Market Competition by Manufacturers including Production, Share, Revenue,
Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Biosimulation Market Manufacturers Profiles/Analysis including Company Basic Information,
Manufacturing Base and Its Competitors.
• Biosimulation Market Manufacturing Cost Analysis including Key Raw Materials and Key
Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Biosimulation Market Forecast including Production, Consumption, Import and Export Forecast
by Type, Applications and Region.
• Research Findings and Conclusion
Accelerated drug discovery development process by key players to favor market growth
Pharmaceutical companies, non-profit organizations, and healthcare regularity organizations are majorly
investing in research and development of drug discovery process. Market players are engaged in
exploiting biosimulation techniques for enhancing efficacy of drug discovery and development process,
which is expected to drive growth of the biosimulation market. Government of various economies are
funding initiatives such as Innovate UK and Horizon 2020 provide businesses and research organizations
with grants to drive scientific research. Innovate UK is the UK’s innovation agency and part of UK
Research and Innovation, which supported two companies, Adorial Pharma Limited and C4X Discovery,
in enabling the development of a novel mathematical-based system of drug discovery.
Global Key Players
Key players operating in biosimulation market include Certara, L.P., Simulations Plus, Inc., Dassault
Systèmes (Accelrys), Genedata AG, LeadScope, Inc., Compugen Inc., Schrödinger, LLC, In Silico
Biosciences, Inc., Advanced Chemistry Development, Inc., Chemical Computing Group ULC, Physiomics
PLC, and Pharmaceutical Product Development, LLC (Evidera).
Detailed Segmentation:
Global Biosimulation Market, By Product & Services:
Global Biosimulation Market, By Application:
Drug Discovery
Drug Development
Browse Research Report @
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]

Market players are engaged in developing novel biosimulation platform, in order to offer tailored solution in each therapeutic area. This is expected to aid in growth of the market.